Discovery Bioanalysis

Discovery Bioanalysis

We give a fast fit-to reason bioanalytical benefit for in vitro and in vivo discovery studies. We attempt quantitative LC-MS/MS investigation of medications, metabolites, and biomarkers in a scope of matrices, including plasma, blood, dried blood spots (DBS), urine, bile, tissue homogenate and in vitro tests. We can give bioanalytical information and logical direction to help discovery studies including PK, PKPD and exploratory toxicology. We offer a layered way to deal with bioanalysis, extending from basic, for the most part, nonexclusive philosophies to pre-qualified measures consolidating bespoke technique improvement.

OUR CAPABILITIES INCLUDE
  • Rapid LC/MS/MS method development and validation
  • Supporting ADME screening, and preclinical PK and PD efficacy studies
  • Small molecule to large biologic testing
  • Biological matrices like blood, plasma, bile, urine, feces, and tumor tissue collection
  • GLP-like SOP, QA, and QC implemented.